Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Druilhe

Showing results (181-190 of 185) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 185 results.
Infection and Immunity|August 14, 2001
Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicityM Theisen, D Dodoo, A Toure-Balde, et al.
Infection and Immunity|September 30, 2009
Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165cS Olugbile, C Kulangara, G Bang, et al.
Genes and Immunity|August 20, 2004
Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSFM Sedegah, Y Charoenvit, J Aguiar, et al.
Scandinavian Journal of Immunology|March 31, 2004
Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levelsL J M Carvalho, S G Oliveira, M Theisen, et al.
Nature Medicine|November 14, 2000
Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3P Daubersies, A W Thomas, P Millet, et al.
Pageof 19

Showing results (181-190 of 185) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 185 results.
Infection and Immunity|August 14, 2001
Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicityM Theisen, D Dodoo, A Toure-Balde, et al.
Infection and Immunity|September 30, 2009
Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165cS Olugbile, C Kulangara, G Bang, et al.
Genes and Immunity|August 20, 2004
Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSFM Sedegah, Y Charoenvit, J Aguiar, et al.
Scandinavian Journal of Immunology|March 31, 2004
Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levelsL J M Carvalho, S G Oliveira, M Theisen, et al.
Nature Medicine|November 14, 2000
Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3P Daubersies, A W Thomas, P Millet, et al.
Pageof 19